cells by regulating cell cycle proteins, reducing DNA synthesis, and other ways (Perrone et al., 2015). Studies have shown

ABSTRACT

Background: Liver cancer is a complex disease, and the upregulation of Nrf2, a key molecule in the Keap1/ARE signaling pathway, is expected to become a new method for liver cancer and prevention. Curcumin is a natural antioxidant, and polydopamine nanoparticles, as a new type of nano-drug carrier, have excellent biocompatibility and drug-loading performance and can improve the targeting and efficacy of drugs. Objectives: This study aims to explore the effect of polydopamine nanoparticle-encapsulated curcumin on upregulating the expression of Nrf2 through the Keap1/ARE signaling pathway, thereby improving liver damage in mice with liver cancer and providing new strategies and basis for the treatment and prevention of liver cancer. Materials and Methods: After the H22 cell culture and liver cancer mouse model were established, they were divided into groups for the study of the mechanism of action of the prepared polydopamine nanoparticles-coated curcumin (CUR-PDA NPs), and the effect of CUR-PDA NPs expression on inhibition of cell proliferation and migration, promotion of apoptosis, and delaying liver cancer progression was studied through animal experiments. This process is related to the Keap1/ARE signaling pathway and Nrf2 expression. The mechanism is further verified by Add-Nrf2, Nrf2-shRNA, Keap1-shRNA, and other methods. Results: CUR-PDA NPs upregulate the expression of Nrf2 through the Keap1/ARE signaling pathway to improve liver injury in mice with liver cancer. There is an interaction between the expression of CUR-PDA NPs and Keap1. Increasing the expression of Keap1 can inhibit the activation of Nrf2, thereby inhibiting the anti-oxidant and detoxification mechanisms, resulting in reduced cell survival rate, increased apoptosis rate, reduced migration, and reduced levels of IL-1β and TNF-α. Conclusion: CUR-PDA NPs upregulates the expression of Nrf2 through the Keap1/ARE signaling pathway to improve liver injury in mice with liver cancer. This provides new strategies and a basis for liver cancer treatment and prevention.

KEYWORDS

• Polydopamine nanoparticles
• curcumin
• Keap1/ARE
• Nrf2
• liver cancer
• liver injury

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296251313613Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 21, ISSUE 4Reserpine Ameliorates 1,2-Dimethylhydrazineinduced Colon Cancer through Regulating Xenobiotic Enzymes and Bax/Caspases/Bcl2-mediated Apoptotic Mechanisms in RatsWenli He, Lina He · pp. 1165–1175Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 4Study on the Neuroprotective Mechanism of Salidroside Modified with Polydopamine Nanoparticles in Regulating Notch Pathway by Inhibiting miR-155 in Stroke Ratsactivity of AQP, TLR TLR, Song Liu, Xiaomeng Lv, Dong Wang · pp. 1176–1186Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 4Exploring Beta-sitosterol’s Role in Breast Cancer Treatment via Integrated Network Pharmacological Analysis and in vitro ValidationJiaxing Yu, Shuqin Cheng, Zelin Ye, Ming Zhang, Xinlei Zhao · pp. 1201–1211Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 4Artemetin Inhibits Cell Growth and Activates Caspase-dependent Apoptotic Cell Death Colon Cancer HCT-116 CellsYan Chen, Lu Men · pp. 1212–1219Original Research ArticleSame type: Article